Synthesis, radiolabeling and biodistribution of morphine glucuronide (mor-glu)

The aim of this study was to synthesize a glucuronide conjugated morphine derivative which could be labeled with 131 I, as a radiopharmaceutical, and to investigate its radiopharmaceutical potential using biodistribution studies in male Albino Wistar rats. Morphine was extracted from dry capsules of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of radioanalytical and nuclear chemistry 2012-03, Vol.291 (3), p.849-857
Hauptverfasser: Enginar, H., Unak, P., Biber Müftüler, F. Z., Lambrecht, F. Y., Medine, E. I., Yolcular, S., Yurt Kilcar, A., Seyitoğlu, B., Bulduk, I.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The aim of this study was to synthesize a glucuronide conjugated morphine derivative which could be labeled with 131 I, as a radiopharmaceutical, and to investigate its radiopharmaceutical potential using biodistribution studies in male Albino Wistar rats. Morphine was extracted from dry capsules of the opium poppy ( Papaver somniferum L.). It was conjugated with UDP-glucuronic acid by using UDP-glucuronyl transferase (UDPGT) enzyme rich microsomes, purified by high performance liquid chromatography (HPLC) and characterized by nuclear magnetic resonance (NMR), infrared (IR) spectroscopy and liquid chromatography mass spectroscopy (LC-MS/MS). Normal and receptor blockage biodistribution studies were performed in male Albino Wistar rats. The results of the tissue distribution studies showed that 131 I labeled morphine glucuronide ( 131 I-mor-glu) uptake in the small intestine, large intestine and urinary bladder was higher than in the other tissues of the rats in the blocked receptor and unblocked receptor. A greater uptake of the radio labeled substance was observed in the hypothalamus and mid brain than in the other branches of the rats’ brains.
ISSN:0236-5731
1588-2780
DOI:10.1007/s10967-011-1412-4